Beacon Equity Research

Beacon Equity Research was an independent investment research firm that specialized in providing equity analysis and investor relations services for small-cap and micro-cap companies, with a significant focus on the biotechnology and healthcare sectors. The firm was primarily known for its 'issuer-sponsored' research model, where companies paid for the production and distribution of detailed analyst reports to increase market visibility. These reports typically included fundamental analysis, valuation models, and industry comparisons intended for both institutional and retail investors. While the firm operated within the life sciences ecosystem by analyzing emerging drug developers, it did not engage in any internal R&D or clinical activities. Beacon Equity Research was most active during the mid-2000s and early 2010s but has since become inactive.